On the other hand, knock-down of ANO1 upregulated in BPH promoted a decrease in only pAKT, implying that ANO1 affects the pathogenesis of BPH through the AKT signaling pathway [29]. This evidence concerns the gene ANO1 and benign prostatic hyperplasia.